Peer Reviewed Publications

  1. Elbeik T, Shults K, Patterson BK. Simultaneous Ultrasensitive Subpopulation Staining/Hybridization In Situ: Multiplex Analyses of Transcriptionally Active HIV-1 Intact Cell Reservoirs. Future Virol. 2012 Aug;7(8):741-744. View from link to Future Medicine
  2. Shults K, Flye-Blakemore L, Patterson BK, Elbeik T. Analysis of multiple cell reservoirs expressing unspliced HIV-1 gag-pol mRNA in patients on antiretroviral therapy. Future Virol. 2012 Aug;7(8):819-832. PubMed PMID: 23125871; PubMed Central PMCID: PMC3486786. View from link to PubMed
  3. Cherepakhina NE, Shogenov ZS, Elbeik T, Akhmedilova KA, Agirov MM, Tabaksoeva ZhA, Ogneva EA, Matsuura E, Mukhin NA, Shoenfeld Y, Pal’tsev MA, Suchkov SV.[Post-infectious clinical-immunological syndrome and its place in clinical practice]. Ter Arkh. 2009;81(12):71-8. Review. Russian. PubMed PMID: 20481055. View from link to PubMed
  4. Lan YC, Elbeik T, Dileanis J, Ng V, Chen YJ, Leu HS, Cheng SH, Wong JC, Wong WW, Chen YM. Molecular epidemiology of HIV-1 subtypes and drug resistant strains in Taiwan. J Med Virol. 2008 Feb;80(2):183-91. PubMed PMID: 18098141. View from link to PubMed
  5. Shogenov ZS, Kekenadze NN, Vorob’eva SE, Usik MP, Elbeik T, Akhmedilova KA, Mamonova EE, Matsuura E, Pal’tsev MA, Suchkov SV. [Architectonics of cell subpopulations of peripheral blood in patients with autoimmune myocarditis: clinical and pathogenetic aspects]. Ter Arkh. 2008;80(12):23-8. Russian. PubMed PMID: 19227902. View from link to PubMed
  6. Elbeik T, Dalessandro R, Loftus RA, Beringer S. HIV-1 and HCV viral load cost models for bDNA: 440 Molecular System versus real-time PCR AmpliPrep/TaqMan test. Expert Rev Mol Diagn. 2007 Nov;7(6):723-53. PubMed PMID: 18020903. View from link to PubMed
  7. Elbeik T, Loftus RA, Beringer S. Cost assessment of the automated VERSANT 440 Molecular System versus the semi-automated System 340 bDNA Analyzer platforms. Expert Rev Mol Diagn. 2007 Nov;7(6):713-22. PubMed PMID: 18020902. View from link to PubMed
  8. Suchkov SV, Petrunin DD, Kostalevskaya AV, Kachkov IA, Elbeik T, Matsuura E, Paltsev MA. Cancer-associated immune-mediated syndromes: Pathogenic values and clinical implementation. Biomed Pharmacother. 2007 Jul;61(6):323-37. Epub 2007 Jul 5. PubMed PMID: 17656060. View from link to PubMed
  9. Mazo EB, Vinnitskĭ LI, Litvinov VA, Cherepakhina NE, Burdakova IuA, Elbeik T, Mukhin NA, Pal’tsev MA, Suchkov SV. [Chronic pyelonephritis: immunopathogenesis and clinicodiagnostic value of its specific features]. Ter Arkh. 2007;79(1):85-9. Review. Russian. PubMed PMID: 17385475. View from link to PubMed
  10. Elbeik T, Nassos P, Kipnis P, Haller B, Ng VL. Evaluation of the VACUTAINER PPT Plasma Preparation Tube for use with the Bayer VERSANT assay for quantification of human immunodeficiency virus type 1 RNA. J Clin Microbiol. 2005 Aug;43(8):3769-71. PubMed PMID: 16081908; PubMed Central PMCID: PMC1233973. View from link to PubMed
  11. Roland ME, Elbeik TA, Kahn JO, Bamberger JD, Coates TJ, Krone MR, Katz MH, Busch MP, Martin JN. HIV RNA testing in the context of nonoccupational postexposure prophylaxis. J Infect Dis. 2004 Aug 1;190(3):598-604. Epub 2004 Jul 7. PubMed PMID: 15243937. View from link to PubMed
  12. Elbeik T, Markowitz N, Nassos P, Kumar U, Beringer S, Haller B, Ng V. Simultaneous runs of the Bayer VERSANT HIV-1 version 3.0 and HCV bDNA version 3.0 quantitative assays on the system 340 platform provide reliable quantitation and improved work flow. J Clin Microbiol. 2004 Jul;42(7):3120-7. PubMed PMID: 15243070; PubMed Central PMCID: PMC446273. View from link to PubMed
  13. Elbeik T, Surtihadi J, Destree M, Gorlin J, Holodniy M, Jortani SA, Kuramoto K, Ng V, Valdes R Jr, Valsamakis A, Terrault NA. Multicenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA). J Clin Microbiol. 2004 Feb;42(2):563-9. PubMed PMID: 14766817; PubMed Central PMCID: PMC344448. View from link to PubMed
  14. Cuchkov SV, Moskalets OV, Cherepakhina NE, Burdakova IuA, Suntsova IG, Shumskiĭ VI, Shaĭkhaev GO, Elbeik T, Beringer S, Petrauskene O. [Modern methods immunological and genetical diagnostics in clinical practice]. Ter Arkh. 2004;76(4):78-83. Review. Russian. PubMed PMID: 15174330. View from link to PubMed
  15. Abrams DI, Hilton JF, Leiser RJ, Shade SB, Elbeik TA, Aweeka FT, Benowitz NL, Bredt BM, Kosel B, Aberg JA, Deeks SG, Mitchell TF, Mulligan K, Bacchetti P, McCune JM, Schambelan M. Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial. Ann Intern Med. 2003 Aug 19;139(4):258-66. PubMed PMID: 12965981. View from link to PubMed
  16. Elbeik T, Chen YM, Soutchkov SV, Loftus RA, Beringer S. Global cost modeling analysis of HIV-1 and HCV viral load assays. Expert Rev Pharmacoecon Outcomes Res. 2003 Aug;3(4):383-407. doi: 10.1586/14737167.3.4.383. PubMed PMID: 19807450. View from link to PubMed
  17. Gleaves CA, Welle J, Campbell M, Elbeik T, Ng V, Taylor PE, Kuramoto K, Aceituno S, Lewalski E, Joppa B, Sawyer L, Schaper C, McNairn D, Quinn T. Multicenter evaluation of the Bayer VERSANT HIV-1 RNA 3.0 assay: analytical and clinical performance. J Clin Virol. 2002 Aug;25(2):205-16. PubMed PMID: 12367656. View from link to PubMed
  18. Elbeik T, Loftus RA, Beringer S. Health care industries’ perspective of viral load assays: the VERSANT HIV-1 RNA 3.0 assay. Expert Rev Mol Diagn. 2002 May;2(3):275-85. PubMed PMID: 12050866. View from link to PubMed
  19. Elbeik T, Alvord WG, Trichavaroj R, de Souza M, Dewar R, Brown A, Chernoff D, Michael NL, Nassos P, Hadley K, Ng VL. Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5. J Acquir Immune Defic Syndr. 2002 Apr 1;29(4):330-9. PubMed PMID: 11917236. View from link to PubMed
  20. Elbeik T, Hoo BS, Campodonico ME, Dileanis J, Fay FF, Bortolozzi RL, Benetti MS, Fay OH, Marlowe N, Petrauskene O, Chernoff D, Smith L, Ng VL. In vivo emergence of drug-resistant mutations at less than 50 HIV-1 RNA copies/mL that are maintained at viral rebound in longitudinal plasma samples from human immunodeficiency virus type-1-infected patients on highly active antiretroviral therapy. J Hum Virol. 2001 Nov-Dec;4(6):317-28. PubMed PMID: 12082398. View from link to PubMed
  21. Elbeik T, Charlebois E, Nassos P, Kahn J, Hecht FM, Yajko D, Ng V, Hadley K. Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5. J Clin Microbiol. 2000 Mar;38(3):1113-20. PubMed PMID: 10699005; PubMed Central PMCID: PMC86352. View from link to PubMed
  22. Locher CP, Grant RM, Collisson EA, Reyes-Terán G, Elbeik T, Kahn JO, Levy JA. Antibody and cellular immune responses in breakthrough infection subjects after HIV type 1 glycoprotein 120 vaccination. AIDS Res Hum Retroviruses. 1999 Dec 10;15(18):1685-9. PubMed PMID: 10606091. View from link to PubMed
  23. Haslett PA, Klausner JD, Makonkawkeyoon S, Moreira A, Metatratip P, Boyle B, Kunachiwa W, Maneekarn N, Vongchan P, Corral LG, Elbeik T, Shen Z, Kaplan G. Thalidomide stimulates T cell responses and interleukin 12 production in HIV-infected patients. AIDS Res Hum Retroviruses. 1999 Sep 1;15(13):1169-79. PubMed PMID: 10480630. View from link to PubMed
  24. Deeks SG, Hecht FM, Swanson M, Elbeik T, Loftus R, Cohen PT, Grant RM. HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy. AIDS. 1999 Apr 16;13(6):F35-43. PubMed PMID: 10397555. View from link to PubMed
  25. Liegler TJ, Yonemoto W, Elbeik T, Vittinghoff E, Buchbinder SP, Greene WC. Diminished spontaneous apoptosis in lymphocytes from human immunodeficiency virus-infected long-term nonprogressors. J Infect Dis. 1998 Sep;178(3):669-79. PubMed PMID: 9728534. View from link to PubMed
  26. Fiscus SA, Hughes MD, Lathey JL, Pi T, Jackson B, Rasheed S, Elbeik T, Reichman R, Japour A, Byington R, Scott W, Griffith BP, Katzenstein DA, Hammer SM. Changes in virologic markers as predictors of CD4 cell decline and progression of disease in human immunodeficiency virus type 1-infected adults treated with nucleosides. AIDS Clinical Trials Group Protocol 175 Team. J Infect Dis. 1998 Mar;177(3):625-33. PubMed PMID: 9498441. View from link to PubMed
  27. Lathey JL, Hughes MD, Fiscus SA, Pi T, Jackson JB, Rasheed S, Elbeik T, Reichman R, Japour A, D’Aquila RT, Scott W, Griffith BP, Hammer SM, Katzenstein DA. Variability and prognostic values of virologic and CD4 cell measures in human immunodeficiency virus type 1-infected patients with 200-500 CD4 cells/mm(3) (ACTG 175). AIDS Clinical Trials Group Protocol 175 Team. J Infect Dis. 1998 Mar;177(3):617-24. PubMed PMID: 9498440. View from link to PubMed
  28. Hughes MD, Johnson VA, Hirsch MS, Bremer JW, Elbeik T, Erice A, Kuritzkes DR, Scott WA, Spector SA, Basgoz N, Fischl MA, D’Aquila RT. Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team. Ann Intern Med. 1997 Jun 15;126(12):929-38. PubMed PMID: 9182469. View from link to PubMed
  29. Katzenstein DA, Hammer SM, Hughes MD, Gundacker H, Jackson JB, Fiscus S, Rasheed S, Elbeik T, Reichman R, Japour A, Merigan TC, Hirsch MS. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team. N Engl J Med. 1996 Oct 10;335(15):1091-8. Erratum in: N Engl J Med 1997 Oct 9;337(15):1097. PubMed PMID: 8813039. View from link to PubMed
  30. Hartley CA, Gilbert MJ, Brigido L, Elbeik T, Levy JA, Crowe SM, Mills J. Human immunodeficiency virus grown in CD4-expressing cells is associated with CD4. J Gen Virol. 1996 Sep;77 ( Pt 9):2015-23. PubMed PMID: 8810998. View from link to PubMed
  31. Harrer T, Harrer E, Kalams SA, Elbeik T, Staprans SI, Feinberg MB, Cao Y, Ho DD, Yilma T, Caliendo AM, Johnson RP, Buchbinder SP, Walker BD. Strong cytotoxic  T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res Hum Retroviruses. 1996 May 1;12(7):585-92. PubMed PMID: 8743084. View from link to PubMed
  32. Harrer T, Harrer E, Kalams SA, Barbosa P, Trocha A, Johnson RP, Elbeik T, Feinberg MB, Buchbinder SP, Walker BD. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J Immunol. 1996 Apr 1;156(7):2616-23. PubMed PMID: 8786327. View from link to PubMed
  33. Levy JA, Ramachandran B, Barker E, Guthrie J, Elbeik T. Plasma viral load, CD4+ cell counts, and HIV-1 production by cells. Science. 1996 Feb 2;271(5249):670-1. PubMed PMID: 8571134. View from link to PubMed
  34. Staprans SI, Hamilton BL, Follansbee SE, Elbeik T, Barbosa P, Grant RM, Feinberg MB. Activation of virus replication after vaccination of HIV-1-infected individuals. J Exp Med. 1995 Dec 1;182(6):1727-37. PubMed PMID: 7500017; PubMed Central PMCID: PMC2192265. View from link to PubMed
  35. Safrin S, Phan L, Elbeik T. A comparative evaluation of three methods of antiviral susceptibility testing of clinical herpes simplex virus isolates. Clin Diagn Virol. 1995 Jul;4(1):81-91. PubMed PMID: 15566830. View from link to PubMed
  36. Kahn JO, Steimer KS, Baenziger J, Duliege AM, Feinberg M, Elbeik T, Chesney M, Murcar N, Chernoff D, Sinangil F. Clinical, immunologic, and virologic observations related to human immunodeficiency virus (HIV) type 1 infection in a volunteer in an HIV-1 vaccine clinical trial. J Infect Dis. 1995 May;171(5):1343-7. PubMed PMID: 7751714. View from link to PubMed
  37. Lathey JL, Fiscus SA, Rasheed S, Kappes JC, Griffith BP, Elbeik T, Spector SA, Reichelderfer PS. Optimization of quantitative culture assay for human immunodeficiency virus from plasma. Plasma Viremia Group Laboratories of the AIDS Clinical Trials Group (National Institute of Allergy and Infectious Diseases). J Clin Microbiol. 1994 Dec;32(12):3064-7. PubMed PMID: 7883903; PubMed Central PMCID: PMC264230. View from link to PubMed
  38. Safrin S, Elbeik T, Phan L, Robinson D, Rush J, Elbaggari A, Mills J. Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 1994 Jun;38(6):1246-50. PubMed PMID: 8092821; PubMed Central PMCID: PMC188193. View from link to PubMed
  39. Safrin S, Elbeik T, Mills J. A rapid screen test for in vitro susceptibility of clinical herpes simplex virus isolates. J Infect Dis. 1994 Apr;169(4):879-82. PubMed PMID: 8133105. View from link to PubMed
  40. Choudhury S, Woodworth CD, Inamdar A, El-Beik T, DiPaolo JA, Rosenthal LJ. Differences in retention and expression of transfected human cytomegalovirus Towne XbaI-E transforming fragment in human cervical and NIH 3T3 lines. Intervirology. 1992;33(4):187-96. PubMed PMID: 1326497. View from link to PubMed
  41. Crowe SM, Mills J, Elbeik T, Lifson JD, Kosek J, Marshall JA, Engleman EG, McGrath MS. Human immunodeficiency virus-infected monocyte-derived macrophages express surface gp120 and fuse with CD4 lymphoid cells in vitro: a possible mechanism of T lymphocyte depletion in vivo. Clin Immunol Immunopathol. 1992 Nov;65(2):143-51. PubMed PMID: 1356673. View from link to PubMed
  42. Crowe SM, Elbeik T, Ulrich PP, Mills J, Moss A. Lack of evidence of occult human immunodeficiency virus in seronegative individuals at very high risk of infection. J Med Virol. 1991 Nov;35(3):160-4. PubMed PMID: 1804928. View from link to PubMed
  43. Crowe SM, McGrath MS, Elbeik T, Kirihara J, Mills J. Comparative assessment of antiretrovirals in human monocyte-macrophages and lymphoid cell lines acutely and chronically infected with the human immunodeficiency virus. J Med Virol. 1989 Nov;29(3):176-80. PubMed PMID: 2533247. View from link to PubMed
  44. Ulrich PP, Busch MP, El-Beik T, Shiota J, Vennari J, Shriver K, Vyas GN. Assessment of human immunodeficiency virus expression in cocultures of peripheral blood mononuclear cells from healthy seropositive subjects. J Med Virol. 1988 May;25(1):1-10. PubMed PMID: 3411308. View from link to PubMed
  45. El-Beik T, Razzaque A, Jariwalla R, Cihlar RL, Rosenthal LJ. Multiple transforming regions of human cytomegalovirus DNA. J Virol. 1986 Nov;60(2):645-52. PubMed PMID: 3021997; PubMed Central PMCID: PMC288937. View from link to PubMed